Alere to divest assets to Quidel for FTC approval of Abbott deal
MLex Summary: Medical testing company Alere has agreed to divest assets to Quidel, a provider of diagnostic healthcare products, in connection with the US Federal Trade Commission's antitrust review of the...To view the full article, register now.
Already a subscriber? Click here to view full article